Filing Details

Accession Number:
0001144204-16-093743
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-04-11 18:18:56
Reporting Period:
2016-04-07
Filing Date:
2016-04-11
Accepted Time:
2016-04-11 18:18:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326190 Pharmathene Inc PIP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1313876 I Eric Richman C/O Pharmathene, Inc.,
One Park Place, Suite 450
Annapolis MD 21401
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.0001 Par Value Per Share Acquisiton 2016-04-07 5,367 $1.76 182,189 No 4 M Direct
Common Stock, $0.0001 Par Value Per Share Disposition 2016-04-07 5,367 $2.20 176,822 No 4 S Direct
Common Stock, $0.0001 Par Value Per Share Acquisiton 2016-04-08 6,400 $1.76 183,222 No 4 M Direct
Common Stock, $0.0001 Par Value Per Share Disposition 2016-04-08 6,400 $2.20 176,822 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2016-04-07 5,367 $0.00 5,367 $1.76
Common Stock Employee Stock Option (right to buy) Disposition 2016-04-08 6,400 $0.00 6,400 $1.76
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
19,633 2012-09-30 2021-09-30 No 4 M Direct
13,233 2012-09-30 2021-09-30 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.0001 Par Value Per Share 10,000 Indirect See Footnote
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2015.
  2. Held indirectly as previously reported on Form 4 dated November 10, 2011.